A Stierlé

646 total citations
16 papers, 530 citations indexed

About

A Stierlé is a scholar working on Hematology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, A Stierlé has authored 16 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Molecular Biology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in A Stierlé's work include Platelet Disorders and Treatments (7 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers) and Phosphodiesterase function and regulation (4 papers). A Stierlé is often cited by papers focused on Platelet Disorders and Treatments (7 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers) and Phosphodiesterase function and regulation (4 papers). A Stierlé collaborates with scholars based in France, Switzerland and Morocco. A Stierlé's co-authors include Jean‐Pierre Cazenave, Alain Beretz, François Lanza, Robert Anton, Daniel Hanau, Alan T. Nurden, Martine Morales, Gwénaëlle André, Dominique J. Fournier and Christian Gachet and has published in prestigious journals such as Journal of Clinical Investigation, Biochemical and Biophysical Research Communications and Biochemical Pharmacology.

In The Last Decade

A Stierlé

16 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Stierlé France 11 181 150 127 95 64 16 530
JM Gerrard Canada 15 285 1.6× 78 0.5× 213 1.7× 59 0.6× 36 0.6× 27 661
J.A. Lynham United Kingdom 10 158 0.9× 164 1.1× 387 3.0× 29 0.3× 39 0.6× 11 730
Natalia Rukoyatkina Russia 13 148 0.8× 119 0.8× 188 1.5× 10 0.1× 37 0.6× 28 481
Xingwen Da China 11 37 0.2× 92 0.6× 201 1.6× 17 0.2× 51 0.8× 16 435
Armel Fradin France 10 36 0.2× 36 0.2× 249 2.0× 18 0.2× 67 1.0× 14 524
Jutta Meyer-Kirchrath Germany 15 47 0.3× 146 1.0× 211 1.7× 23 0.2× 52 0.8× 24 652
Petra Quass Germany 12 14 0.1× 182 1.2× 358 2.8× 40 0.4× 44 0.7× 18 575
Moua Yang United States 13 68 0.4× 81 0.5× 263 2.1× 11 0.1× 83 1.3× 34 527
Yingqing Huo China 11 42 0.2× 48 0.3× 269 2.1× 34 0.4× 30 0.5× 15 506
Nidhal Ben Amor Tunisia 14 57 0.3× 37 0.2× 170 1.3× 7 0.1× 36 0.6× 22 536

Countries citing papers authored by A Stierlé

Since Specialization
Citations

This map shows the geographic impact of A Stierlé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Stierlé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Stierlé more than expected).

Fields of papers citing papers by A Stierlé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Stierlé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Stierlé. The network helps show where A Stierlé may publish in the future.

Co-authorship network of co-authors of A Stierlé

This figure shows the co-authorship network connecting the top 25 collaborators of A Stierlé. A scholar is included among the top collaborators of A Stierlé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Stierlé. A Stierlé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Lanza, François, A Stierlé, Dominique J. Fournier, et al.. (1992). A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg----214Trp mutation.. Journal of Clinical Investigation. 89(6). 1995–2004. 99 indexed citations
2.
Toti, Florence, Christian Gachet, Philippe Ohlmann, et al.. (1992). Electrophoretic Studies on Molecular Defects of von Willebrand Factor and Platelet Glycoprotein llb-llla with Antibodies Produced in Egg Yolk from Laying Hens. Pathophysiology of Haemostasis and Thrombosis. 22(1). 32–40. 10 indexed citations
3.
Lanza, François, A Stierlé, Christian Gachet, & Jean‐Pierre Cazenave. (1992). Differential effects of extra- and intracellular calcium chelation on human platelet function and glycoprotein IIb-IIIa complex stability.. PubMed. 34(1). 123–31. 6 indexed citations
4.
Gachet, Christian, A Stierlé, Philippe Ohlmann, et al.. (1991). Normal ADP-Induced Aggregation and Absence of Dissociation of the Membrane GP IIb-IIIa Complex of Intact Rat Platelets Pretreated with EDTA. Thrombosis and Haemostasis. 66(2). 246–253. 9 indexed citations
5.
Faradji, A., A. Bohbot, Serge Dumont, et al.. (1991). Apheresis-Elutriation Program for Adoptive Immunotherapy with Autologous Activated Monocytes in Cancer Patients. The International Journal of Artificial Organs. 14(5). 304–312. 15 indexed citations
6.
Gachet, Christian, A Stierlé, Jean‐Pierre Cazenave, et al.. (1990). The thienopyridine PCR 4099 selectively inhibits ADP-induced platelet aggregation and fibrinogen binding without modifying the membrane glycoprotein IIb–IIIa complex in rat and in man. Biochemical Pharmacology. 40(2). 229–238. 56 indexed citations
7.
Lanza, François, et al.. (1988). Epinephrine potentiates human platelet activation but is not an aggregating agent. American Journal of Physiology-Heart and Circulatory Physiology. 255(6). H1276–H1288. 107 indexed citations
8.
Lanza, François, et al.. (1987). Platelet functions, α2-adrenergic receptors and cytoplasmic free calcium are normal in the myotonic dystrophy of Steinert. Journal of the Neurological Sciences. 79(1-2). 13–22. 4 indexed citations
9.
10.
11.
Beretz, Alain, et al.. (1986). Inhibition of human platelet cyclic AMP phosphodiesterase and of platelet aggregation by a hemisynthetic flavonoid, amentoflavone hexaacetate. Biochemical Pharmacology. 35(2). 257–262. 29 indexed citations
12.
13.
Lugnier, Claire, A Stierlé, Alain Beretz, et al.. (1983). Tissue and substrate specificity of inhibition by alkoxy-aryl-lactams of platelet and arterial smooth muscle cyclic nucleotide phosphodiesterases relationship to pharmacological activity. Biochemical and Biophysical Research Communications. 113(3). 954–959. 46 indexed citations
14.
Beretz, Alain, A Stierlé, Robert Anton, & Jean‐Pierre Cazenave. (1982). Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin. Biochemical Pharmacology. 31(22). 3597–3600. 74 indexed citations
15.
Cazenave, Jean‐Pierre, Alain Beretz, A Stierlé, & Raymond F. Anton. (1981). Role Of Cyclic Amp In The Inhibition Of Human Platelet Functions By Quercetin, A Flav0N0Id That Potentiates PGI2 Effect. Thrombosis and Haemostasis. 1 indexed citations
16.
Ilien, Brigitte, A Stierlé, Claire Lugnier, J.C. Stoclet, & Yves Landry. (1978). Separation of three cyclic-nucleotide-phosphodiesterases from bovine aorta. Biochemical and Biophysical Research Communications. 83(2). 486–492. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by JM Gerrard Breakdown of academic impact, for papers by J.A. Lynham Breakdown of academic impact, for papers by Natalia Rukoyatkina Breakdown of academic impact, for papers by Xingwen Da Breakdown of academic impact, for papers by Armel Fradin Breakdown of academic impact, for papers by Jutta Meyer-Kirchrath Breakdown of academic impact, for papers by Petra Quass Breakdown of academic impact, for papers by Moua Yang Breakdown of academic impact, for papers by Yingqing Huo Breakdown of academic impact, for papers by Nidhal Ben Amor
Rankless by CCL
2026